# ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE
> **ANDA077337** · Abbreviated New Drug Application (Generic) · Sponsor: TEVA · Approved 2017-05-19
## Drug
- **FDA Application Number:** ANDA077337
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE
- **Generic name:** Metformin Hydrochloride
- **Active ingredients:** METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** TEVA
- **First approval:** 2017-05-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077337)
---
*AI Analytics · CC0 1.0*